"Hyperkalemia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Abnormally high potassium concentration in the blood, most often due to defective renal excretion. It is characterized clinically by electrocardiographic abnormalities (elevated T waves and depressed P waves, and eventually by atrial asystole). In severe cases, weakness and flaccid paralysis may occur. (Dorland, 27th ed)
| Descriptor ID |
D006947
|
| MeSH Number(s) |
C18.452.950.396
|
| Concept/Terms |
Hyperkalemia- Hyperkalemia
- Hyperkalemias
- Hyperpotassemia
- Hyperpotassemias
|
Below are MeSH descriptors whose meaning is more general than "Hyperkalemia".
Below are MeSH descriptors whose meaning is more specific than "Hyperkalemia".
This graph shows the total number of publications written about "Hyperkalemia" by people in this website by year, and whether "Hyperkalemia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 1 | 1 |
| 2003 | 1 | 1 | 2 |
| 2008 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 2 | 0 | 2 |
| 2021 | 4 | 0 | 4 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hyperkalemia" by people in Profiles.
-
Financial Implication of Sodium Zirconium Cyclosilicate Therapy in Patients with Systolic Heart Failure and Hyperkalemia. Int Heart J. 2023 Nov 30; 64(6):1065-1070.
-
Hyperkalemia Risk with Finerenone: Results from the FIDELIO-DKD Trial. J Am Soc Nephrol. 2022 01; 33(1):225-237.
-
Sodium bicarbonate administration and subsequent potassium concentration in hyperkalemia treatment. Am J Emerg Med. 2021 Dec; 50:132-135.
-
Management of hyperkalemia in chronic heart failure using sodium zirconium cyclosilicate. Clin Cardiol. 2021 Sep; 44(9):1272-1275.
-
Combination Therapy Using Sodium Zirconium Cyclosilicate and a Mineralocorticoid Receptor Antagonist in Patients with Heart Failure and Hyperkalemia. Intern Med. 2021; 60(13):2093-2095.
-
Effect of KBP-5074 on Blood Pressure in Advanced Chronic Kidney Disease: Results of the BLOCK-CKD Study. Hypertension. 2021 07; 78(1):74-81.
-
Incidence and Clinical Significance of Hyperkalemia Following Heart Transplantation. Transplant Proc. 2021 Mar; 53(2):673-680.
-
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes. N Engl J Med. 2020 12 03; 383(23):2219-2229.
-
Knowledge Does Not Correspond to Adherence of Renal Diet Restrictions in Patients With Chronic Kidney Disease Stage 3-5. J Ren Nutr. 2021 Jul; 31(4):351-360.
-
Evolution of Patiromer Use: a Review. Curr Cardiol Rep. 2020 07 09; 22(9):94.